We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
Cap. Flow
-$3.21B
Cap. Flow %
-7.47%
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$285M
2
AMAT icon
Applied Materials
AMAT
+$234M
3
MU icon
Micron Technology
MU
+$185M
4
MRK icon
Merck
MRK
+$161M
5
NXPI icon
NXP Semiconductors
NXPI
+$152M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$505M
2
BAC icon
Bank of America
BAC
+$339M
3
NKE icon
Nike
NKE
+$335M
4
UNP icon
Union Pacific
UNP
+$329M
5
C icon
Citigroup
C
+$277M

Sector Composition

Rank Sector Weight
1 Technology 23.49%
2 Financials 16.82%
3 Consumer Discretionary 16.55%
4 Healthcare 14.39%
5 Industrials 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPL icon
1226
Texas Pacific Land
TPL
$23.5B
$1.51M ﹤0.01%
17,406
-126,909
-88% -$9.28M
CUBI icon
1227
Customers Bancorp
CUBI
$2.77B
$1.51M ﹤0.01%
+63,433
New +$1.46M
HLX icon
1228
Helix Energy Solutions
HLX
$1.41B
$1.49M ﹤0.01%
+154,872
New +$1.34M
ECOM
1229
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$1.49M ﹤0.01%
+164,689
New +$1.51M
ROCC
1230
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$1.48M ﹤0.01%
+48,855
New +$1.3M
CBIO
1231
Crescent Biopharma
CBIO
$626M
$1.48M ﹤0.01%
+2,796
New +$1.51M
MTRX icon
1232
Matrix Service
MTRX
$335M
$1.48M ﹤0.01%
64,520
-18,534
-22% -$366K
AR icon
1233
Antero Resources
AR
$10.7B
$1.47M ﹤0.01%
515,692
+429,092
+495% +$1.1M
BGSF icon
1234
BGSF Inc
BGSF
$60M
$1.47M ﹤0.01%
66,969
+10,934
+20% +$223K
BWB icon
1235
Bridgewater Bancshares
BWB
$603M
$1.46M ﹤0.01%
106,054
+22,611
+27% +$287K
JAX
1236
DELISTED
J. Alexander's Holdings, Inc.
JAX
$1.45M ﹤0.01%
152,083
+29,796
+24% +$301K
STRL icon
1237
Sterling Infrastructure
STRL
$16.7B
$1.45M ﹤0.01%
103,108
+22,317
+28% +$336K
KKR icon
1238
KKR & Co
KKR
$92.3B
$1.45M ﹤0.01%
+49,700
New +$1.42M
USDP
1239
DELISTED
USD PARTNERS LP
USDP
$1.44M ﹤0.01%
145,450
-77,445
-35% -$765K
NPO icon
1240
Enpro
NPO
$7.05B
$1.44M ﹤0.01%
+21,449
New +$1.43M
ZS icon
1241
Zscaler
ZS
$27.3B
$1.44M ﹤0.01%
30,866
-298,940
-91% -$13.9M
LSAK icon
1242
Lesaka Technologies
LSAK
$420M
$1.43M ﹤0.01%
382,998
-10,800
-3% -$35.8K
NRIM icon
1243
Northrim BanCorp
NRIM
$587M
$1.42M ﹤0.01%
148,564
+21,224
+17% +$203K
MANT
1244
DELISTED
Mantech International Corp
MANT
$1.42M ﹤0.01%
+17,800
New +$1.33M
VVNT
1245
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$1.41M ﹤0.01%
+137,325
New +$1.41M
DXPE icon
1246
DXP Enterprises
DXPE
$2.98B
$1.41M ﹤0.01%
+35,454
New +$1.32M
BYD icon
1247
Boyd Gaming
BYD
$6.06B
$1.41M ﹤0.01%
47,107
-5,393
-10% -$152K
IRBT
1248
DELISTED
iRobot
IRBT
$1.41M ﹤0.01%
+27,756
New +$1.39M
ABR icon
1249
Arbor Realty Trust
ABR
$998M
$1.4M ﹤0.01%
+97,500
New +$1.39M
HUBG icon
1250
HUB Group
HUBG
$2.92B
$1.4M ﹤0.01%
+54,486
New +$1.35M

Similar funds

Arrowstreet Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.

  • Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
  • Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
  • Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
  • Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
  • Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
  • Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
  • Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.

Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.